Stay updated on Pembrolizumab+Capecitabine+Bevacizumab in MSS Colorectal Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab+Capecitabine+Bevacizumab in MSS Colorectal Cancer Clinical Trial page.

Latest updates to the Pembrolizumab+Capecitabine+Bevacizumab in MSS Colorectal Cancer Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedRevision tag updated from v3.6.5 to v3.6.6 on the page, indicating a new revision of the study record metadata.SummaryDifference0.0%

- Check18 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe page now displays a server error (500) with an 'An error occurred' message, indicating the requested study page is currently unavailable. As a result, no study details are accessible at this time.SummaryDifference21%

- Check47 days agoChange DetectedThe page revision label was updated from v3.6.3 to v3.6.4, indicating a minor platform update. No study content changes are reflected in this update.SummaryDifference0.0%

- Check61 days agoChange DetectedAdded a new citation by Bocobo A. et al. to Publications for a 2026 Clin Colorectal Cancer article (Phase II study of pembrolizumab plus capecitabine and bevacizumab). Removed the previous Online ahead of print citation (Clin Colorectal Cancer, 2026 Feb 18:S1533-0028(26)00010-1).SummaryDifference0.0%

- Check68 days agoChange DetectedRevision tag on the page updated from v3.6.2 to v3.6.3, signaling a new patch or update to the page. The visible content remains unchanged.SummaryDifference0.0%

- Check75 days agoChange DetectedRevision: v3.6.2 has been added, replacing Revision: v3.6.0. This reflects a page version update rather than any changes to the study details or eligibility information.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab+Capecitabine+Bevacizumab in MSS Colorectal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab+Capecitabine+Bevacizumab in MSS Colorectal Cancer Clinical Trial page.